ライフサイエンスコーパス: spleen necrosis virus

コーパス検索結果 (１語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します

1 troviruses such as murine leukemia virus and spleen necrosis virus.

2 ements from Moloney murine sarcoma virus and spleen necrosis virus.

3 inal posttranscriptional control elements in spleen necrosis virus and human foamy virus RNA and supp

4 rated by 1 kb are 4 and 4.7% in one round of spleen necrosis virus and murine leukemia virus replicat

5 avian reticuloendotheliosis group including spleen necrosis virus, and baboon endogenous virus, use

6 Moloney murine sarcoma virus and spleen necrosis virus are type C retroviruses that belon

7 he retroviral mutation rates, we developed a spleen necrosis virus-based in vivo system to selectivel

8 ing of RNA and DNA templates, we constructed spleen necrosis virus-based retroviral vectors containin

9 We constructed spleen necrosis virus-based retroviral vectors containin

10 r and intermolecular template switching, two spleen necrosis virus-based vectors were constructed.

11 ructs derived from murine leukemia virus and spleen necrosis virus by replacing an NC flanking region

12 ted into the long terminal repeat (LTR) of a spleen necrosis virus shuttle vector, and proviruses wer

13 It has been documented that spleen necrosis virus (SNV) can package murine leukemia

14 The 5' long terminal repeat (LTR) of spleen necrosis virus (SNV) contains a unique posttransc

15 One exception is that spleen necrosis virus (SNV) does not contain a well-defi

16 The 5' long terminal repeat of spleen necrosis virus (SNV) facilitates Rev/Rev-responsi

17 The RU5 region at the 5' RNA terminus of spleen necrosis virus (SNV) has been shown to facilitate

18 Spleen necrosis virus (SNV) is an amphotropic type C ret

19 Previous work has shown that spleen necrosis virus (SNV) long terminal repeats (LTRs)

20 ucleoside analog 5-azacytidine increased the spleen necrosis virus (SNV) mutation rate 13-fold in one

21 cy direct repeat deletions are not unique to spleen necrosis virus (SNV) or the neomycin drug resista

22 on, we tested whether p12 can be replaced by spleen necrosis virus (SNV) p18, human immunodeficiency

23 Spleen necrosis virus (SNV) proteins can package RNA fro

24 ted retroviral vector particles derived from spleen necrosis virus (SNV) that display a single-chain

25 The ability of the nonlentiviral retrovirus spleen necrosis virus (SNV) to cross-package the genomic

26 nd protein analyses determined the 5' UTR of spleen necrosis virus (SNV), reticuloendotheliosis virus

27 ed retroviral vector particles, derived from spleen necrosis virus (SNV), that display the antigen bi

28 eered C-type retroviral vectors derived from spleen necrosis virus (SNV), which are capable of infect

29 Spleen necrosis virus (SNV)-based and murine leukemia vi

30 otein, an HIV-1-based vector expressing Nef, spleen necrosis virus (SNV)-Nef virus (i.e., SNV vector

31 e packaged and propagated by the proteins of spleen necrosis virus (SNV).

32 tion cycle is 4% for markers 1.0 kb apart in spleen necrosis virus (SNV).

33 This extends our observation with the spleen necrosis virus system and suggests that high nega

WebLSDに未収録の専門用語（用法）は "新規対訳" から投稿できます。